Cephalon CEO now on indefinite medical leave

Cephalon CEO Frank Baldino won't be returning from medical leave as quickly as the developer once believed. Without saying what Baldino is suffering from, the biotech says that the medical leave, once estimated at four months, will now be for an indefinite period of time. COO J. Kevin Buchi will continue to handle the day-to-day duties at the company. Story

Suggested Articles

Data from a 10,000-patient trial showed that people with osteoarthritis taking Novartis' Ilaris had 40% to 47% lower rates of joint replacements.

Immunic's lead asset beat placebo at reducing damage to myelin, which protects nerve fibers, in patients with relapsing multiple sclerosis.

The appointment sees Kobayashi switch from developing Dermira’s anti-IL-13 drug to advancing Aslan’s would-be rival.